Please wait while the formulary information is being retrieved.
GRISEOFULVIN ULTRAMICROSIZE (griseofulvin ultramicrosize)
- Onychomycosis due to dermatophyte
- Tinea barbae
- Tinea capitis
- Tinea corporis
- Tinea cruris
- Tinea pedis
125 mg tablet
- 2 tablets (250 mg) by oral route every 8 hours
250 mg tablet
- 1 tablet (250 mg) by oral route every 8 hours
Onychomycosis due to dermatophyte
- 2 tablets (250 mg) by oral route every 8 hours
- 2 tablets (250 mg) by oral route 3 times per day
- 1 tablet (250 mg) by oral route every 8 hours
- 1 tablet (250 mg) by oral route 3 times per day
Tinea barbae
- 1 tablet (125 mg) by oral route 3 times per day
- 1 tablet (125 mg) by oral route every 8 hours
- 1 tablet (125 mg) by oral route 3 times per day for 4 weeks
- 1 tablet (125 mg) by oral route 3 times per day for 6 weeks
- 1 tablet (125 mg) by oral route every 8 hours for 4 weeks
- 1 tablet (125 mg) by oral route every 8 hours for 6 weeks
- 1.5 tablets (375 mg) by oral route once daily
- 1.5 tablets (375 mg) by oral route once daily for 4 weeks
- 1.5 tablets (375 mg) by oral route once daily for 6 weeks
Tinea corporis
- 1 tablet (125 mg) by oral route 3 times per day
- 1 tablet (125 mg) by oral route every 8 hours
- 1 tablet (125 mg) by oral route 3 times per day for 4 weeks
- 1 tablet (125 mg) by oral route every 8 hours for 4 weeks
- 1 tablet (125 mg) by oral route 3 times per day for 2 weeks
- 1 tablet (125 mg) by oral route every 8 hours for 2 weeks
- 1.5 tablets (375 mg) by oral route once daily
- 1.5 tablets (375 mg) by oral route once daily for 4 weeks
- 1.5 tablets (375 mg) by oral route once daily for 2 weeks
Tinea cruris
- 1 tablet (125 mg) by oral route 3 times per day
- 1 tablet (125 mg) by oral route every 8 hours
- 1.5 tablets (375 mg) by oral route once daily
Tinea pedis
- 1 tablet (250 mg) by oral route 3 times per day for 4 weeks
- 1 tablet (250 mg) by oral route 3 times per day for 8 weeks
- 1 tablet (250 mg) by oral route every 8 hours for 4 weeks
- 1 tablet (250 mg) by oral route every 8 hours for 8 weeks
- 2 tablets (250 mg) by oral route 3 times per day for 4 weeks
- 2 tablets (250 mg) by oral route 3 times per day for 8 weeks
- 2 tablets (250 mg) by oral route every 8 hours for 4 weeks
- 2 tablets (250 mg) by oral route every 8 hours for 8 weeks
- 2 tablets (250 mg) by oral route every 8 hours
- 2 tablets (250 mg) by oral route 3 times per day
- 1 tablet (250 mg) by oral route every 8 hours
- 1 tablet (250 mg) by oral route 3 times per day
- None
Contraindicated
- Altavera (28)
- Alyacen 1/35 (28)
- Alyacen 7/7/7 (28)
- Amethia
- Amethia Lo
- Amethyst
- Apri
- Aranelle (28)
- Aubra
- Aviane
- Azurette (28)
- Balziva (28)
- Beyaz
- Brevicon (28)
- Briellyn
- Camila
- Camrese
- Camrese Lo
- Caziant (28)
- Chateal
- Cryselle (28)
- Cyclafem 1/35 (28)
- Cyclafem 7/7/7 (28)
- Cyclessa (28)
- Dasetta 1/35 (28)
- Dasetta 7/7/7 (28)
- Daysee
- Depo-provera
- Depo-subq Provera 104
- desog-e.estradiol/e.estradiol
- Desogen
- desogestrel-ethinyl estradiol
- drospirenone-e.estradiol-lm.FA
- drospirenone-ethinyl estradiol
- Elinest
- Emoquette
- Enpresse
- Enskyce
- Errin
- Estarylla
- estradiol valerate-dienogest
- Estrostep Fe-28
- ethynodiol diac-eth estradiol
- etonogestrel
- etonogestrel-ethinyl estradiol
- Falmina (28)
- Femcon Fe
- Generess Fe
- Gianvi (28)
- Gildagia
- Gildess
- Gildess Fe
- Heather
- Introvale
- Jencycla
- Jolessa
- Jolivette
- Junel 1.5/30 (21)
- Junel 1/20 (21)
- Junel Fe 1.5/30 (28)
- Junel Fe 1/20 (28)
- Kariva (28)
- Kelnor 1/35 (28)
- Kurvelo
- L norgest&E estradiol-E estrad
- Larin 1/20 (21)
- Larin Fe
- Leena 28
- Lessina
- Levonest (28)
- levonorg-eth estrad triphasic
- levonorgestrel
- levonorgestrel-ethinyl estrad
- Levora 0.15/30 (28)
- Levora-28
- Lo Loestrin Fe
- Loestrin 1.5/30 (21)
- Loestrin 1/20 (21)
- Loestrin Fe 1.5/30 (28)
- Loestrin Fe 1/20 (28)
- Lomedia 24 Fe
- Loryna (28)
- Loseasonique
- Low-ogestrel (28)
- Lutera (28)
- Lyza
- Marlissa
- medroxyprogesterone
- Microgestin 1.5/30 (21)
- Microgestin 1/20 (21)
- Microgestin Fe 1.5/30 (28)
- Microgestin Fe 1/20 (28)
- Minastrin 24 Fe
- Mircette (28)
- Mirena
- Modicon (28)
- Mono-linyah
- Mononessa (28)
- My Way
- Myzilra
- Natazia
- Necon 0.5/35 (28)
- Necon 1/35 (28)
- Necon 1/50 (28)
- Necon 10/11 (28)
- Necon 7/7/7 (28)
- Nexplanon
- Next Choice One Dose
- Nor-qd
- Nora-be
- norelgestrom-ethinyl estradiol
- noreth-ethinyl estradiol-iron
- norethin-e.estradiol triphasic
- norethin-eth estrad biphasic
- norethindrone (contraceptive)
- norethindrone ac-eth estradiol
- norethindrone-e.estradiol-iron
- norethindrone-ethin estradiol
- norethindrone-mestranol
- norgestimate-ethinyl estradiol
- norgestrel-ethinyl estradiol
- Norinyl 1+35 (28)
- Norinyl 1+50 (28)
- Nortrel 0.5/35 (28)
- Nortrel 1/35 (21)
- Nortrel 1/35 (28)
- Nortrel 7/7/7 (28)
- Nuvaring
- Ocella
- Ogestrel (28)
- Orsythia
- Ortho Evra
- Ortho Micronor
- Ortho Tri-cyclen (28)
- Ortho Tri-cyclen Lo (28)
- Ortho-cept (28)
- Ortho-cyclen (28)
- Ortho-novum 1/35 (28)
- Ortho-novum 7/7/7 (28)
- Ovcon-35 (28)
- Philith
- Pimtrea (28)
- Pirmella
- Plan B One-step
- Portia
- Previfem
- Quartette
- Quasense
- Reclipsen (28)
- Safyral
- Seasonique
- Skyla
- Sprintec (28)
- Sronyx
- Syeda
- Tilia Fe
- Tri-estarylla
- Tri-legest Fe
- Tri-linyah
- Tri-norinyl (28)
- Tri-previfem (28)
- Tri-sprintec (28)
- Trinessa (28)
- Trivora (28)
- Velivet Triphasic Regimen (28)
- Vestura (28)
- Viorele (28)
- Vyfemla (28)
- Wera (28)
- Wymzya Fe
- Yasmin (28)
- Yaz 28
- Zarah
- Zenchent (28)
- Zenchent Fe
- Zeosa
- Zovia 1/35E (28)
- Zovia 1/50E (28)
Severe
Moderate
- Coumadin
- Jantoven
- warfarin
- Hepatic failure
- Porphyria
- Pregnancy
Contraindicated
- Abnormal hepatic function tests
Severe
Moderate
- Alcoholism
- Granulocytopenic disorder
- Lupus-like syndrome
- Systemic lupus erythematosus
GRISEOFULVIN ULTRAMICROSIZE (griseofulvin ultramicrosize)
- Onychomycosis due to dermatophyte
- Tinea barbae
- Tinea capitis
- Tinea corporis
- Tinea cruris
- Tinea pedis
- None
- Headache disorder
More Frequent
Severe
Less Severe
- Acute confusion
- Granulocytopenic disorder
- Hepatitis
- Leukopenia
- Oral candidiasis
- Peripheral neuropathy
- Skin photosensitivity
- Skin rash
- Urticaria
- Diarrhea
- Dizziness
- Fatigue
- Gastrointestinal irritation
- Insomnia
- Nausea
- Proteinuria
- Vomiting
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Abnormal hepatic function tests
- Angioedema
- Erythema multiforme
- Hyperbilirubinemia
- Lupus-like syndrome
- Stevens-johnson syndrome
- Toxic epidermal necrolysis
Less Severe
- None
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
None
Griseofulvin
- Severity Level:
1
- Additional Notes: Not recommended for use in preg per mfr, two cases of conjoined twins.
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Griseofulvin
Molecular weight low enough for possible breastmilk excretion
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Molecular weight low enough for possible breastmilk excretion |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Onychomycosis due to dermatophyte | |
| B35.1 | Tinea unguium |
| Tinea barbae | |
| B35.0 | Tinea barbae and tinea capitis |
| Tinea capitis | |
| B35.0 | Tinea barbae and tinea capitis |
| Tinea corporis | |
| B35.4 | Tinea corporis |
| Tinea cruris | |
| B35.6 | Tinea cruris |
| Tinea pedis | |
| B35.3 | Tinea pedis |
| 0-9 | A-Z |
|---|---|
| B35.0 | Tinea barbae and tinea capitis |
| B35.0 | Tinea barbae and tinea capitis |
| B35.1 | Tinea unguium |
| B35.3 | Tinea pedis |
| B35.4 | Tinea corporis |
| B35.6 | Tinea cruris |
Formulary Reference Tool